A detailed history of American Portfolios Advisors transactions in Eiger Bio Pharmaceuticals, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 2,250 shares of EIGR stock, worth $21,375. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,250
Holding current value
$21,375
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$6.04 - $9.66 $13,590 - $21,735
2,250 New
2,250 $16.9 Million
Q1 2022

Mar 21, 2023

BUY
$3.84 - $9.74 $5,760 - $14,610
1,500 Added 66.67%
3,750 $31.1 Million
Q2 2020

Mar 24, 2023

BUY
$5.4 - $13.37 $675 - $1,671
125 Added 20.83%
725 $6.96 Million
Q1 2020

Mar 24, 2023

SELL
$4.91 - $14.7 $8,101 - $24,255
-1,650 Reduced 73.33%
600 $4.08 Million
Q4 2019

Mar 24, 2023

SELL
$9.77 - $15.66 $16,120 - $25,839
-1,650 Reduced 73.33%
600 $8.94 Million
Q3 2019

Mar 24, 2023

BUY
$9.59 - $12.0 $3,836 - $4,800
400 Added 200.0%
600 $6.15 Million
Q2 2019

Mar 24, 2023

SELL
$9.54 - $14.96 $19,557 - $30,668
-2,050 Reduced 91.11%
200 $2.12 Million
Q3 2018

Mar 24, 2023

SELL
$9.6 - $12.9 $19,680 - $26,445
-2,050 Reduced 91.11%
200 $2.4 Million

Others Institutions Holding EIGR

About Eiger BioPharmaceuticals, Inc.


  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $418M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.